BioSpace News Archive

ANANDA Scientific Inc today announced approval by the U.S. Food and Drug Administration (FDA) of the Investigational New Drug (IND) application for the clinical trial evaluating Nantheia™ ATL5, an investigational drug using cannabidiol (CBD) in ANANDA’s proprietary delivery technology as an Adjunctive Treatment for Opioid Use Disorder.

Bruker Corporation to Present at the 40 th Annual J.P. Morgan Healthcare Conference.

Enzolytics, Inc. announces production and sale in the U.S. and North America of “Enzolytics IPF Immune™,” a science-backed liquid nutritional supplement that acts to strengthen the body’s immune system.

Akoya Biosciences, Inc. today announced that it will be virtually participating in the 40th Annual J.P. Morgan Healthcare Conference.

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), announced today that it has received approval from the Serbian Medicines and Medical Devices Agency (ALIM) for its Clinical Trial Application (IND equivalent) to conduct a Phase IIb clinical trial with vafidemstat in patients with Borderline Personality Disorder (BPD) in Serbia.

Ascendis Pharma A/S (Nasdaq: ASND) today announced that the Company is scheduled to participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference.

electroCore, Inc., a commercial-stage bioelectronic medicine company, announced that its management team will give a presentation at the H.C. Wainwright BIOCONNECT Virtual Conference.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, today announced the Company will present at the virtual 40th Annual J.P. Morgan Healthcare Conference at 9:00 a.m. ET / 6:00 a.m. PT on Tuesday, January 11, 2022.

Vor Biopharma, a clinical-stage cell and genome engineering company, announced that members of its senior management team will be participating in two upcoming virtual investor conferences.

Cardiff Oncology, Inc. announced that company management will present at the H.C. Wainwright BioConnect Virtual Conference, taking place January 10 – 13, 2022.